3,4-Dimethoxyphenylacetic acid
3,4-Dimethoxyphenylacetic acid structure
|
Common Name | 3,4-Dimethoxyphenylacetic acid | ||
|---|---|---|---|---|
| CAS Number | 93-40-3 | Molecular Weight | 196.200 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 331.4±27.0 °C at 760 mmHg | |
| Molecular Formula | C10H12O4 | Melting Point | 96-98 °C(lit.) | |
| MSDS | Chinese USA | Flash Point | 130.2±17.2 °C | |
|
A metabolite profiling approach to identify biomarkers of flavonoid intake in humans.
J. Nucl. Med. 139 , 2309-14, (2009) Flavonoids are phytochemicals that are widespread in the human diet. Despite limitations in their bioavailability, experimental and epidemiological data suggest health benefits of flavonoid consumption. Valid biomarkers of flavonoid intake may be useful for e... |
|
|
[ON THE EFFECT OF NIKETHAMIDE AND HOMOVERATRIC ACID DIMETHYLAMIDE ON RESPIRATION IN INFANTS].
Monatsschr. Kinderheilkd. 113 , 341-3, (1965)
|
|
|
Quantitative investigation on the urinary excretion and metabolism of 3,4-dimethoxyphenylethylamine in schizophrenics and normal individuals.
Biol. Psychiatry 17(1) , 49-59, (1982) A quantitative method for the detection of DMPEA in urine was developed. It is based on the fluorometric determination of DMPEA in the form of its phosphopyridoxyl derivate. The limit of detection is 2 microgram DMPEA per 1 g creatinine. The DMPEA content was... |
|
|
Excretion of 3,4-dimethoxyphenethylamine (DMPEA) by acute schizophrenics and controls.
Biol. Psychiatry 12(5) , 643-54, (1977)
|
|
|
Effects of dopamine metabolites on locomotor activities and on the binding of dopamine: relevance to the side effects of L-dopa.
Life Sci. 66(22) , 2159-71, (2000) L-dopa is the major treatment for Parkinson's disease (PD), but its efficacy is limited by the presence of dyskinesia. The dyskinesia develops over a period of exposure to L-dopa and is related to the dosage, therefore, the cause may involve inductive changes... |